Navigation Links
Growth attenuation


Growth attenuation is an elective medical treatment which involves administering estrogen to cause closure of the epiphyses of the bones, resulting in a reduced adult height. Since the 1960s this treatment has been performed primarily on children growing toward an adult height considered unacceptably excessive by their parents and doctors. The cultural consensus of what is considered an excessive height justifying treatment has differed in Europe and North America and has risen over the last 4 decades.[1].

Most of the children treated have been girls, with larger numbers treated in Europe than in North America. The height considered unacceptable by parents and doctors has become substantially taller over the last few decades. Very few boys have ever been treated for excessive tallness in North America.

More recently, growth attenuation treatment has been in the news as part of the controversial Ashley Treatment administered to a developmentally disabled girl.

References

  1. ^ Joyce M. Lee and Joel D. Howell.Tall Girls: The Social Shaping of a Medical Therapy Archives of Pediatrics & Adolescent Medicine, Vol. 160 No. 10, October 2006.



'"/>


(Date:9/20/2017)... ... September 20, 2017 , ... “Monique”: is the ... situations. “Monique” is the creation of published author, Colleen Crispi, has owned four beauty ... Crispi has been involved in real estate and cooking. , “The doctor’s office ...
(Date:9/19/2017)... ... ... Only a few physicians were selected to receive the prestigious 2016 Patients' Choice ... . The founder and medical director of Clevens Face and Body Specialists , ... and the University of Michigan. He has served patients throughout Central Florida and beyond ...
(Date:9/19/2017)... ... 2017 , ... PAPA Healthcare, Inc. announced today, the release ... helps fill gaps, provide essential insights, and improve productivity.” The story focuses ... PAPA Healthcare’s post-acute productivity and analytics solutions. , St. Vincent’s Home Infusion provides ...
(Date:9/19/2017)... ... 19, 2017 , ... Peter Chandonait, Abt Associates Principal Scientist ... (PMI) Africa Indoor Residual Spraying (AIRS) Project , has been named the Grand ... Action Award, a USAID Catalyst Award, recognizes USAID staff and implementing partners who ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... devoted exclusively to funding innovative lymphoma research and serving the lymphoma community through ... return to Texas as a part of its national Swirl: A Wine Tasting ...
Breaking Medicine News(10 mins):
Other medicine definition